Table 3.
Absolute and relative frequency distribution of subjects with vulvovaginal candidiasis according to symptoms before and after treatment in the two treatment groups (fluconazole-placebo and fluconazole-protexin).
| Groups | Fluconazole + placebo | Fluconazole + protexin | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symptoms | Index | Intergroup comparison | |||||||||
| Before treatment | After treatment | Intergroup | Before treatment | After treatment | Intragroup | ||||||
| Total | Percent | Total | Percent | comparison McNemar | Total | Percent | Total | Percent | comparison McNemar | ||
| Vulva inflammation and redness | 10 | 22.2 | 3 | 6.7 | 0.016 | 17 | 37.8 | 7 | 15.6 | 0.002 | NS Fisher |
| Vulva edema | 18 | 40 | 7 | 15.6 | 0.001 | 15 | 33.4 | 5 | 11.1 | 0.002 | NS Chi-square |
| pH < 4.5 | 41 | 91.2 | 42 | 93.4 | 0.50 | 42 | 93.4 | 44 | 97.8 | 0.50 | NS Chi-square |